Evidence map›Paper›PMID 38635053›Full record

ArticleArchives of toxicology2024

Vascular endothelial dysfunction induced by 3-bromofluoranthene via MAPK-mediated-NFκB pro-inflammatory pathway and intracellular ROS generation.

Chien-Ying Lee, Sheng-Wen Wu, Jiann-Jou Yang, Wen-Ying Chen, Chun-Jung Chen, Hsin-Hung Chen, Yi-Chia Lee, Chun-Hung Su, Yu-Hsiang Kuan

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2025
    Article
  4. Review
  5. Review
  6. Plant-derived extracellular vesicles in facial aesthetics.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Chien-Ying LeeDepartment of Pharmacology, School of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Jianguo N. Rd., Taichung, 402, Taiwan, ROC.
Sheng-Wen WuDivision of Nephrology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Jiann-Jou YangDepartment of BioMedical Sciences, Chung Shan Medical University, Taichung, Taiwan.
Wen-Ying ChenDepartment of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan.
Chun-Jung ChenDepartment of Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Hsin-Hung ChenDivision of Endocrinology and Metabolism, Department of Internal Medicine, Asia University Hospital, Taichung, Taiwan.
Yi-Chia LeeDepartment of Pharmacology, School of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Jianguo N. Rd., Taichung, 402, Taiwan, ROC.
Chun-Hung Su *Department of Internal Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Yu-Hsiang Kuan *Department of Pharmacology, School of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Jianguo N. Rd., Taichung, 402, Taiwan, ROC. kuanyh@csmu.edu.tw.ORCID 0000-0002-8991-6394
Chung Shan Medical University Hospital · TWAsia University · TWChung Shan Medical University · TWNational Chung Hsing University · TWTaichung Veterans General Hospital · TW

Funding

Chung Shan Medical University CSMU-INT-112Chung Shan Medical University Hospital CSH-2022-C-002Chung Shan Medical University Hospital CSH-2023-C-022National Chung-Shan Institute of Science and Technology NCHU-CSMU-11110National Science and Technology Council of Taiwan 109-2320-B-040-MY3National Science and Technology Council of Taiwan 111-2314-B-040 -008-
6 · The paper itself

Abstract

3-Bromofluoranthene (3-BrFlu) is the secondary metabolite of fluoranthene, which is classified as a polycyclic aromatic hydrocarbon, through bromination and exists in the fine particulate matter of air pollutants. Endothelial dysfunction plays a critical role in the pathogenesis of cardiovascular and vascular diseases. Little is known about the molecular mechanism of 3-BrFlu on endothelial dysfunction in vivo and in vitro assay. In the present study, 3-BrFlu included concentration-dependent changes in ectopic angiogenesis of the sub-intestinal vein and dilation of the dorsal aorta in zebrafish. Disruption of vascular endothelial integrity and up-regulation of vascular endothelial permeability were also induced by 3-BrFlu in a concentration-dependent manner through pro-inflammatory responses in vascular endothelial cells, namely, SVEC4-10 cells. Generation of pro-inflammatory mediator PGE2 was induced by 3-BrFlu through COX2 expression. Expression of COX2 and generation of pro-inflammatory cytokines, including TNFα and IL-6, were induced by 3-BrFlu through phosphorylation of NF-κB p65, which was mediated by phosphorylation of MAPK, including p38 MAPK, ERK and JNK. Furthermore, generation of intracellular ROS was induced by 3-BrFlu, which is associated with the down-regulated activities of the antioxidant enzyme (AOE), including SOD and catalase. We also found that 3-BrFlu up-regulated expression of the AOE and HO-1 induced by 3-BrFlu through Nrf-2 expression. However, the 3-BrFlu-induced upregulation of AOE and HO-1 expression could not be revised the responses of vascular endothelial dysfunction. In conclusion, 3-BrFlu is a hazardous substance that results in vascular endothelial dysfunction through the MAPK-mediated-NFκB pro-inflammatory pathway and intracellular ROS generation.

Indexed as

Endothelium, VascularFluorenesNF-kappa BReactive Oxygen SpeciesZebrafishAnimalsCapillary PermeabilityCell LineCyclooxygenase 2DinoprostoneDose-Response Relationship, DrugEndothelial CellsInflammationMAP Kinase Signaling SystemMitogen-Activated Protein KinasesCyclooxygenase 2DinoprostoneFluorenesMitogen-Activated Protein KinasesNF-kappa BReactive Oxygen Species3-BromofluorantheneAntioxidative enzymeHO-1MAPKNFκBNrf-2ROSVascular endothelial dysfunction

Identifiers

PMID38635053
PMCPMC11169047
OpenAlexW4394917368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.